Menu ×

HEALTHCARE & PHARMACEUTICAL

Nucleic Acid Labeling Market Analysis by Product Type (Reagents, and Kits); by Labeling Technique (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, and End Labeling); by Application (DNA sequencing, PCR, FISH, Microarray, In Situ Hybridization, Botting, and Others); and by End User (Diagnostic & Research Centers, and Hospitals) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • September28, 2021: ThermoFisher Scientific Inc., announced the launch of Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit. To ensure sample safety, this kit inactivates common respiratory viruses to preserve viral nucleic acids. 

  • May 15, 2019: New England Biolabs (NEB) released Monarch Genomic DNA Purification Kit, by expanding its Monarch Nucleic Acid Purification portfolio. This kit provides extremely high yields of DNA fragment purification and prevents contamination of RNA.

Global Nucleic Acid Labeling Market Size, Forecast, and Trend Highlights Over 2022 - 2031

Nucleic Acid Labeling Market Region Chart

The global nucleic acid labeling market is estimated to garner a revenue of USD 4 Billion by the end of 2031 by growing at a CAGR of ~9% over the forecast period, i.e., 2022 – 2031. Further, the market generated revenue of USD 1 Billion in the year 2021. The market growth can be attributed primarily to the increasing use of polymerase chain reaction (PCR) tests and DNA sequencing across hospitals and laboratory centers owing to the outbreak of various infectious diseases such as the COVID-19 Pandemic. For instance, in February 2021 more than 1 million PCR tests were performed in United States as a consequence of the COVID-19 Pandemic.

Nucleic Acid Labeling Market Region

Get more information on this report: Request Sample PDF

Molecular structures such as nucleic acids are responsible for transmitting genetic information. A nucleic acid is composed of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The labeling of nucleic acids can be achieved with enzymes, biotins, and fluorescent tags. Labeling of nucleic acids is used for PCR, fluorescence in situ hybridization (FISH), microarrays, blotting, in situ hybridization, as well as DNA sequencing. Moreover, the development in healthcare facilities, increasing awareness of early diseases diagnosis along with increasing per capita income is anticipated to propel the demand for nucleic acid labeling during the forecast period. The World Bank reported a 4.8% increase in worldwide income per capita in 2021, compared with 1.5% in 2019.

Global Nucleic Acid Labeling Market: Growth Drivers and Challenges

Growth Drivers

  • Increase In Laboratory Experiments and Research Institutes- Data from the World Bank shows that as of 2018, there were 1597 researchers engaged in research and development activities per 1,000,000 people, a significant increase from 1412 researchers per million in 2015. Government organizations are increasing funding for research activities and drug discovery purposes, which is resulting in the development of advanced and innovative treatments for disease diagnosis. There are few companies that offer specific reagents and kits for nucleic acid labeling specifically for research applications which in turn is expected to enlarge the global nucleic acid labeling market size during the forecast period. 

  • Growing Cases of Infectious Diseases Worldwide- It was observed that in China the reportable infectious diseases cases accounted for more than 6,300,170 in 2020. 

  • Rapid Growth of the Life Science Industry Including Cell And Gene Therapy- According to estimates, nearly USD 10 billion investment was made in CGT (cell and gene therapy) in 2020 and the investment is expected to grow to USD ~45Billion by the end of 2027.

  • Increasing Health Care Expenditures Worldwide - According to the World Bank, global healthcare expenditures totaled USD 9.83 billion in 2019, an increase of USD 9.7 billion from 2018.

  • Rise In Genomic Research and Development Initiatives- For instance, by increasing the diversity of people participating in genomics research, the National Human Genome Research Institute (NHGRI) is engaged in improving understanding of human genomic variation and genomic information in general.

Challenges

  • Inadequacies In Professional And Medical Expertise 
  • High Treatment Procedure Costs 
  • Complications Associated With The Techniques

The global nucleic acid labeling market is segmented and analyzed for demand and supply by product type into reagents, and kits. Among these segments, the kits segment is anticipated to capture the largest market size in the global nucleic acid labeling market. The growing application of DNA labeling and detection products for detection and purification is expected to drive segment growth during the forecast period. Moreover, the surge in cases of COVID-19 along with the development of advanced labeling kits by key manufacturers is further anticipated to fuel segment growth. For instance, Perkin Elmer Inc's new COVID-19 nucleic acid detection kit is an in vitro real-time RT-PCR diagnostic kit for detecting nucleic acid from SARS-CoV-2 in humans with 48 tests included in the kit. 

Major Macro-Economic Indicators Impacting the Market Growth

Nucleic Acid Labeling Market

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Nucleic Acid Labeling Market Regional Synopsis

Regionally, the global nucleic acid labeling market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031 backed by the growing genomics research, attractive reimbursement policies, and convenient access to new diagnostics solutions owing to the presence of key emerging companies in the region. Furthermore, the increasing spending on healthcare and medicare along with increased R&D expenditures are expected to drive the nucleic acid labeling market growth in the region during the forecast period. According to the Centers for Medicare & Medicaid Services, a total of USD 4.1 trillion was spent on health care in the United States in 2020, representing an increase of 9.7 percent. Also in 2020, medicare expenditures increased by 3.5% to USD 829.5 billion.

Nucleic Acid Labeling Market Regional Synopsis

Get more information on this report: Request Sample PDF

The global nucleic acid labeling market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global nucleic acid labeling market includes the following segments:

By Product Type

  • Reagents
  • Kits

By Labeling Technique

  • PCR
  • Nick Translation
  • Random Primer
  • In Vitro Transcription
  • Reverse Transcription
  • End Labeling

By Application

  • DNA sequencing
  • PCR
  • FISH
  • Microarray
  • In Situ Hybridization
  • Botting
  • Others

By End User

  • Diagnostic & Research Centers
  • Hospitals
 

Top Featured Companies Dominating the Global Nucleic Acid Labeling Market

  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • New England Biolabs
  • PerkinElmer Inc.
  • F. Hoffmann La-Roche AG
  • GENERAL ELECTRIC COMPANY
  • Merck KGaA
  • Enzo Biochem Inc.
  • Promega Corporation
  • Vector Laboratories
  • Agilent Technologies, Inc.,
  • LubioScience GmbH

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved